Joel Rothman - 02 Jan 2024 Form 4 Insider Report for Equillium, Inc. (EQ)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Jan 2024, 18:14:08 UTC
Prior SEC filing
04 Jan 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jason A. Keyes, Attorney-in-Fact for Joel Rothman

Key filing fact

Joel Rothman filed Form 4 for Equillium, Inc. (EQ) on 03 Jan 2024.

Key facts

  • This page summarizes Joel Rothman's Form 4 filing for Equillium, Inc. (EQ).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jan 2024, 18:14.

Change

  • Previous filing in this sequence was filed on 04 Jan 2023.
  • Current net transaction value: +$13,506.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EQ transaction

Common Stock

Award

Transaction value
$8,400
Shares
+15,000
Change %
+44%
Price
$0.5600
Shares after
49,346
Date
09 Jun 2023
Ownership
Direct
Footnotes
F1
EQ transaction

Common Stock

Award

Transaction value
$5,106
Shares
+8,804
Change %
+18%
Price
$0.5800
Shares after
58,150
Date
08 Dec 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+175,000
Change %
Price
$0.000000
Shares after
175,000
Date
02 Jan 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
175,000
Exercise price
$0.7300
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

These shares were acquired by the Reporting Person under the Issuer's 2018 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Footnote F2

Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .